SUZHOU, China and MÖLNDAL, Sweden, Feb. 11, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ('Ribo') and its subsidiary Ribocure Pharmaceuticals AB ('Ribocure') today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results